NCT06528496
- Conditions
- Childhood Neuroblastoma, High-risk Neuroblastoma, Neoplasms, +9 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
High-risk Neuroblastoma
Explore clinical trials studying High-risk Neuroblastoma. Study availability and eligibility vary by location and protocol.
13 public trials
8 recruiting studies
High-risk Neuroblastoma trial results
NCT07549321
- Conditions
- High-risk Neuroblastoma
- Locations
-
- Children's Hospital Colorado Anschutz Medical Aurora, Colorado, United States
- University of Minnesota Masonic Children's Hospital Minneapolis, Minnesota, United States
- The Children's Hospital at Montefiore The Bronx, New York, United States
- Duke University Medical Center Durham, North Carolina, United States
NCT06057948
- Conditions
- High-risk Neuroblastoma, Metastatic Neuroblastoma, Neoplasms, +9 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Consent only) Commack, New York, United States
NCT07502287
- Conditions
- Disease Attributes, Ganglioneuroblastoma, High-risk Neuroblastoma, +15 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT06831552
- Conditions
- High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Connecticut Children's Medical Center Hartford, Connecticut, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
NCT06803875
- Conditions
- High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +10 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT04221035
- Conditions
- High-risk Neuroblastoma, Patient With Insufficient Response Chemoimmunotherapy
- Locations
-
- Sydney children Hospital Sydney, Randwick, Australia
- Children's Cancer Centre, Monash Children's Hospital Clayton, Australia
- Oncology/Haematology Department, Perth Children's Hospital Nedlands, Australia
- Children's Cancer & Haematology Services, John Hunter Children's Hospital New Lambton Heights, Australia
NCT05272371
- Conditions
- High-risk Neuroblastoma
- Locations
-
- University Children Hospital Krakow, Malopolska, Poland
- Conditions
- High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Shaare Zedek Medical Center Jerusalem, Israel
Enrolling by invitation
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
NCT05650749
- Conditions
- Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +18 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States